Sort

Search

01/06/2025 Comprehensive approach to medication-related problems leading to emergency department visits from a gender perspective
Marín-Barcena, C, Puig-Campmany, M, Ruiz-Ramos, J, Carazo-Díaz, C, Vicente-Romero, J, Juanes-Borrego, A. Comprehensive approach to medication-related problems leading to emergency department visits from a gender perspective. EMERGENCIAS. 2025; 37(3)DOI:10.55633/s3me/026.2025. PMID:40531118. IF:6.300(Q1/1D).
01/06/2025 The impact of a multidisciplinary approach on treatment decisions and outcomes in urothelial carcinoma: A systematic review
Acosta, EA, Pelari-Mici, L, Luis, GC, Balanza, CV, Zapatero, A, Romero-Laorden, N, Diez, PT, Caño-Velasco, J, Guerrero-Ramos, F, Moschini, M, Krajewski, W, Del Giudice, F, Soria, F, Laukhtina, E, Mertens, L, Pichler, R, Mori, K, D'Andrea, D, Mari, A, Marcq, G, Teoh, J, Afferi, L, Albisinni, S, Pradere, B, Gallioli, A, Subiela, JD, Manso, LS. The impact of a multidisciplinary approach on treatment decisions and outcomes in urothelial carcinoma: A systematic review. Actas Urologicas Espanolas. 2025; 49(5)DOI:10.1016/j.acuro.2025.501718. PMID:. IF:1.200(Q3/7D).
01/06/2025 DOWN SYNDROME RESULTS IN AN AMPLIFIED INTERFERON RESPONSE TO AMYLOID-ß THAT IS ASSOCIATED WITH PRODROMAL ALZHEIMER'S DISEASE
Mumford, P, Farrell, C, Kammuri, F, Cannavo, C, Banks, G, Yaman, U, Yu, LJL, Stewart, M, Iulita, MF, Wells, S, Salih, D, Belbin, O, Carmona-Iragui, M, Fortea, J, Wiseman, F. DOWN SYNDROME RESULTS IN AN AMPLIFIED INTERFERON RESPONSE TO AMYLOID-ß THAT IS ASSOCIATED WITH PRODROMAL ALZHEIMER'S DISEASE. GLIA. 2025; 73DOI:. PMID:. IF:5.100(Q1/2D).
01/06/2025 Robot-assisted transmesocolic retroperitoneal lymphadenectomy in testicular non-seminomatous germ cell tumors: A promising approach
Palou, J, Casadevall, M, Faba, OR, Gaya, JM, Breda, A. Robot-assisted transmesocolic retroperitoneal lymphadenectomy in testicular non-seminomatous germ cell tumors: A promising approach. Actas Urologicas Espanolas. 2025; 49(5)DOI:10.1016/j.acuro.2025.501687. PMID:39955056. IF:1.200(Q3/7D).
01/06/2025 Bimekizumab clinical efficacy in impactful body regions and health-related quality of life in patients with plaque psoriasis: Data from four phase 3/3b comparator-controlled trial periods
Smith, A, Armstrong, AW, Elewski, B, Rich, P, Augustin, M, Carrascosa, JM, Vender, R, Lambert, J, Pinto, JML, Hoepken, B, Kavanagh, S, Puig, L. Bimekizumab clinical efficacy in impactful body regions and health-related quality of life in patients with plaque psoriasis: Data from four phase 3/3b comparator-controlled trial periods. AUSTRALASIAN JOURNAL OF DERMATOLOGY. 2025; 66DOI:. PMID:. IF:1.800(Q3/6D).
01/06/2025 Characterization of the Cystic Phenotype Associated with Monoallelic ALG8 and ALG9 Pathogenic Variants
Jawaid, T, Elbarougy, DE, Lavu, S, Buia, G, Senum, SR, Olinger, E, Yang, HN, Mcdonnell, SK, Bublitz, JT, Ma, J, Audrézet, MP, Madsen, CD, Schauer, RS, Baker, TA, Gregory, AV, Orr, SE, Barroso-Gil, M, Neatu, R, Joli, G, Dahl, NK, Kline, TL, Gillion, V, Dahan, K, Jouret, F, Perrone, RD, Steinman, TI, Peters, DJM, Gitomer, BY, Watnick, TJ, Coto, E, Chebib, FT, Hogan, MC, Olson, JE, Larson, NB, Ars, E, Halbritter, J, Demoulin, N, Torres, VE, Sayer, JA, Cornec-Le Gall, E, Harris, PC. Characterization of the Cystic Phenotype Associated with Monoallelic ALG8 and ALG9 Pathogenic Variants. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2025; 36(6)DOI:10.1681/ASN.0000000613. PMID:39899384. IF:9.400(Q1/1D).